Colfax Corporation

Provider of orthopedic & fabrication technology products & services under DJO & ESAB brand

Based in DC

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $50K in lobbying spend across 8 quarterly filings, Colfax Corporation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2022.

$50K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$50K
2022$0

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Health Policy Source, INC.

Lobbyists

Keith SniderDaniel BostonGayle Gerdes

Government Agencies Targeted

These are the government entities that Colfax Corporation disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Medicare CME CB Matter

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

America's Health Insurance Plans INC (Ahip)
$96.4M total spend
U S Chamber Institute for Legal Reform
$58.7M total spend
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
National Association of Children's Hospitals (N.a.c.h.)
$38.0M total spend
Walgreen Company
$24.4M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.